| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.05 |